Medpace Holdings Inc (MEDP) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Medpace Holdings Inc ranks 3 of 6 in its cohort on the Closelook composite (63/100) — the cohort is led by DexCom Inc at 66/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
MEDP Medpace Holdings Inc 63 86 74 29 ok 9.7%
NTRA Natera Inc 44 96 22 6 bull 0.1%
DXCM DexCom Inc 66 86 80 35 bull 5%
ARGX argenx NV ADR 64 79 74 27 ok 7.7%
ONC BeiGene, Ltd. 63 75 63 32 ok 8.9%
LNTH Lantheus Holdings Inc 60 69 75 58 info 10.1%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are Medpace Holdings Inc's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Natera Inc (NTRA), DexCom Inc (DXCM), argenx NV ADR (ARGX), BeiGene, Ltd. (ONC), Lantheus Holdings Inc (LNTH).

How does MEDP score against its peers?

Medpace Holdings Inc's composite reads 63/100, ranking 3 of 6 in its cohort as of 2026-09-18; the cohort's highest composite is DexCom Inc at 66/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Diagnostics & Research. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.